oncology innovation

MEQUON, Wis., May 1, 2026 Vector Science & Therapeutics, Inc. has announced the filing of a provisional patent application...

BRISBANE, CALIFORNIA, April 28, 2026 CareDx Inc. has announced a definitive agreement to acquire Naveris, marking a significant expansion...

Mountain View, California, USA – April 23, 2026 RenovoRx announced that a pharmacokinetic (PK) and pharmacodynamic (PD) data abstract...

Paris, France – April 22, 2026 In a major breakthrough for pediatric oncology, Ipsen has announced that the European...

OXFORD, UK, April 20, 2026 Enara Bio announced the presentation of breakthrough preclinical data for ENA101, its first-in-class bispecific...

LOS ANGELES, April 16, 2026 City of Hope announced that its scientists will present groundbreaking research findings on cancer...

HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...

CHANHASSEN, Minnesota, April 9, 2026 Alpheus Medical, Inc. has announced the initiation of its Phase 2b randomized clinical trial...

SHANGHAI, China, April 10, 2026 Oricell Therapeutics Holdings Limited has successfully closed a $110 million pre-IPO financing round, marking...

San Diego, California, USA, April 6, 2026 FDA Engagement Signals Registrational Pathway Progress In a key development for oncolytic...